ALLY THERAPEUTICS
Ally Therapeutics solves the immune response barriers for gene therapy. They are dedicated to solving the immune response issues that limit the safety and efficacy of in vivo gene therapies. It is backed by ARCH, Alta, and UCB Ventures. The company is a new biotech company based in Cambridge, Massachusetts, and was founded in 2018.
ALLY THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.allytx.com
Total Employee:
1+
Status:
Closed
Total Funding:
10 M USD
Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Endpoint Health
Precision Immunology Therapies
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Ovid Therapeutics
Ovid Therapeutic's purpose is to solve intractable medical problems.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Tallac Therapeutics
Tallac Therapeutics offers next generation immunotherapies for cancer patients.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.allytx.com
- Host name: ec2-54-243-117-197.compute-1.amazonaws.com
- IP address: 54.243.117.197
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Ally Therapeutics"
Advancing Therapeutic Discovery Together - alloytx.com
Alloyโs 100+ scientists bring deep and diverse expertise to tackle your hardest projects. Headquartered in Waltham, MA, our global teams include high velocity antibody discovery in Athens, GA, transgenic platform development in โฆ See details»
Alloy Therapeutics - Crunchbase Investor Profile
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty โฆ See details»
Alloy Therapeutics, Inc. Information - RocketReach
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we democratize โฆ See details»
Alloy Therapeutics (Switzerland) AG โ Swiss Biotech
Alloy Therapeutics is a biotechnology ecosystem company democratizing access to tools, technologies, and services for discovering and developing therapeutic biologics across six modalities, including antibodies, TCRs, โฆ See details»
Working At Alloy Therapeutics: Company Overview and Culture
Mar 14, 2024 www.alloytx.com. Organization Type. Private. CEO. Errik Anderson. Social Media. Alloy Therapeutics is a biotech ecosystem company, facilitating affordable, non-exclusive access โฆ See details»
Alloy Therapeutics - workinbiotech.com
Alloy Therapeutics describes itself as a biotechnology ecosystem company that enables pre-competitive drug discovery at all levels. Alloy currently offers licensing in antibody and TCR โฆ See details»
Alloy Therapeutics: Antibody Discovery Services
Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in antibodies and TCRs. See details»
Alloy Therapeutics - VentureRadar
"Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we democratize โฆ See details»
Making better medicines by breaking down barriers to translation
Alloytx.com Making better medicines by breaking down barriers to translation Alloy Therapeutics, a biotechnology ecosystem company, is committed to providing affordable and non-exclusive โฆ See details»
Alloy Therapeutics - Switzerland Innovation Park Basel Area
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners across โฆ See details»
Alloy Therapeutics to empower drug discovery of Lundbeckโs โฆ
May 2, 2023 Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners across โฆ See details»
Careers - Alloy Therapeutics
Careers Advance your career and turn science into medicine Ready to make an impact? Explore opportunities Life at Alloy is about generosity, innovation and collaboration Our mission is โฆ See details»
Alloy Therapeutics Announces Institutional License Agreement with ...
Oct 30, 2024 Join the Alloy Therapeutics community by visiting alloytx.com and following Alloy on LinkedIn. About Scripps Research. Scripps Research is an independent, nonprofit biomedical โฆ See details»
EVOTEC PARTNERS WITH ALLOY THERAPEUTICS TO EXPAND ITS โฆ
For further information, please contact: Gabriele Hansen, SVP Head of Global Corporate Communications & Marketing, [email protected], T. +49.(0)40.560 81-255 ... See details»
Alloy's Drug Discovery Technologies & Services Roadmap
Alloy reinvests 100% of its revenue into innovation and access to innovation, a commitment that enables the organization to continuously improve upon and develop new technologies to support โฆ See details»
Alloy Therapeutics, Inc. (Alloy Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธด โฆ
May 1, 2023 Join the Alloy Therapeutics community by visiting alloytx.com and following Alloy on LinkedIn . About the Alloy Therapeutics Genetic Medicines AntiClastic Antisense Platform โฆ See details»
Integral Molecular Adds Transgenic Humanized Mice to Expand its โฆ
Jan 5, 2022 Alloy Therapeutics (alloytx.com) is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of โฆ See details»
Alloy Therapeutics Raises $42 Million in Series D Financing
The technologies and protocols can be replicated in a partnerโs organization through a platform transfer and as part of an Alloy Innovation Subscription. Alloy is a leader in bispecific antibody โฆ See details»
Lundbeck Leverages Alloy's Drug Discovery Technology
BOSTON, Mass. โ May 2, 2023 โ Alloy Therapeutics, a biotechnology ecosystem company, announced it is collaborating with Lundbeck, a global pharmaceutical company specializing in โฆ See details»
John Lippincott & Kent Bondensgard Join Alloy's Team - alloytx.com
Apr 26, 2023 Alloy now works with over 150 partners and across five additional, adjacent biologic modalities: T-cell Receptors (TCR mimics, TCRs, and CAR-T), genetic medicines, cell therapies, โฆ See details»